BioSpace Interviews Penn Spinout Leaders About Life Sciences Growth in Philadelphia
In an article by BioSpace, Philadelphia is showcased as a major life sciences hub.
Vetigenics secures $6 million seed financing
The funding will be used to further advance clinical-stage programs toward pivotal trials, accelerate preclinical candidates, and scale the company's operations and manufacturing.
Stentix Wins the 2025 Y-Prize
The team behind Stentix plans to continue developing the technology for several adjustable stent applications.
President’s Innovation Prize Winner Jochi Continues to Make Progress
Jochi is now working on creating custom solutions for academic institutions.
Gynuin Accepted into the LifeX Accelerator
Gynuin is focused on developing a medical device to secure immediate postpartum IUDs and prevent unintended pregnancies and complications.
Penn Spinout Verismo Doses First Patient withSynKIR-310 Treatment
This therapy has the potential to prolong T-cell persistence to combat disease relapse.
GEMMABio and Sahay AI Make Technical.ly Philly’s RealLIST of Up-and-Coming Startups
Technical.ly’s annual RealLIST Startups identifies the top young companies in the Philadelphia region who are on track to continue their momentum.
iECURE Reports on Preliminary Clinical Response Data in First Infant Dosed with its in vivo Gene Editing Candidate ECUR-506
iECURE reported preliminary findings from the first infant dosed with its in vivo gene editing candidate ECUR-506.
Sahay AI Wins 1682 Venture Award for Most Promising AI-Driven Startups in Philadelphia
Sahay AI won the 1682 Venture Award, a pitch competition for early-stage AI-driven startups based in Philadelphia.
ViTToria Biotherapeutics Announces Dosing of First Patient in Phase 1 Clinical Trial of its VIPER-101 T-Cell Therapy
ViTToria has dosed the first patient in its Phase 1 clinical trial for VIPER-101.